Other G9a small molecule inhibitors like CM-272 and EML-741 that have demonstrated anti-tumoural and anti-neoplastic effects in different cancer sub-types, however more studies need to be carried out to investigate their effects on chemoresistance (Feoli et al., 2022). This evidence concerns the gene EHMT2 and cancer.